Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral F-02-2-Na Tablets in Adult Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study is evaluating the safety, tolerability, and pharmacokinetics of oral F-02-2-Na tablets in adults with hyperuricemia with or without gout; enroll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• F-02-2-Na (F-02-2-Na)

Snippet

Sponsor: Guangdong Hengqin Novagains Biopharmaceutical Co., Ltd. | Conditions: Hyperuricemia With or Without Gout | Phase 1 | Status: ENROLLING_BY_INVITATION